Technology

BioNTech SE

$104.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.68 (+1.63%) As of 3:58 PM UTC today

Why Robinhood?

You can buy or sell BioNTech SE and other stocks, options, and ETFs commission-free!

About BNTX

BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. The listed name for BNTX is BioNTech SE American Depositary Share.

CEO
Ugur Sahin
Employees
1,310
Headquarters
Mainz, Rheinland-Pfalz
Founded
2008
Market Cap
24.53B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.09M
High Today
$106.00
Low Today
$103.20
Open Price
$104.00
Volume
701.61K
52 Week High
$131.00
52 Week Low
$28.00

Collections

BNTX Earnings

-$1.03
-$0.69
-$0.34
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, Pre-Market

You May Also Like

AKUS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure